MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617086184 A) filed by Federal State Budgetary Institution Russian Scientific Center Of Roentgenoradiology Rscrr Of The on July 14, 2026, for Ras-Gtpase Inhibitor And Use Thereof To Treat Oncological Diseases.
Inventors include Bojenko, Vladimir Konstantinovich; Kulinich, Tatyana Mikhailovna; Solodky, Vladimir Alekseevich; Kukoleva, Elena Anatolyevna; Goncharov, Sergey Vladimirovich; and Kudinova, Elena Alexandrovna.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The invention relates to the field of biotechnology and medicine, and more particularly to a polypeptide having the amino acid sequence SEQ ID NO: 1 and being capable of inhibiting RAS-GTPase activity, to the use of said polypeptide to produce a drug for treating stomach cancer or rectal cancer in a dose of 0.81-3.00 mg/kg, as well as to a drug based on said polypeptide for the treatment of stomach cancer or rectal cancer, and to a method for treating stomach cancer or rectal cancer by intraperitoneally administering said drug to a subject in an amount of 150 ml twice at an interval of 7 days.
Disclaimer: Curated by HT Syndication.
